Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ivabradine in patients with heart failure: a systematic literature review.
Khan ZM, Briere JB, Olewinska E, Khrouf F, Nikodem M. Khan ZM, et al. Among authors: briere jb. J Mark Access Health Policy. 2023 Oct 4;11(1):2262073. doi: 10.1080/20016689.2023.2262073. eCollection 2023. J Mark Access Health Policy. 2023. PMID: 37808119 Free PMC article.
Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation.
Coleman CI, Briere JB, Fauchier L, Levy P, Bowrin K, Toumi M, Millier A, Taieb V, Wu O. Coleman CI, et al. Among authors: briere jb. J Mark Access Health Policy. 2019 Feb 4;7(1):1574541. doi: 10.1080/20016689.2019.1574541. eCollection 2019. J Mark Access Health Policy. 2019. PMID: 30774786 Free PMC article.
Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review.
Briere JB, Bowrin K, Coleman C, Fauchier L, Levy P, Folkerts K, Toumi M, Taieb V, Millier A, Wu O. Briere JB, et al. Expert Rev Pharmacoecon Outcomes Res. 2019 Feb;19(1):27-36. doi: 10.1080/14737167.2018.1518134. Epub 2018 Sep 19. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 30169975
39 results